Document Detail


Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections.
MedLine Citation:
PMID:  6218755     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Piperacillin sodium (Pipracil, Lederle Laboratories, Wayne, New Jersey), a new semisynthetic penicillin, demonstrated in vitro activity against a broad spectrum of clinical pathogens. It is active against most strains of the clinically important gram-negative aerobic or facultative bacteria and against virtually all the clinically important anaerobic organisms, including Bacteroides fragilis and Bacteroides bivius. This broad antibacterial spectrum suggested that piperacillin might be an effective single antimicrobial agent for the treatment of mixed aerobic/anaerobic infections in obstetric and gynecologic patients. In this study, the clinical efficacy and safety of piperacillin was compared with that of cefoxitin in the management of pelvic infections. There were 23 patients in the piperacillin group (acute salpingitis, 12; endomyometritis, 7; pelvic cellulitis, 2; tuboovarian abscess, 2) and 25 patients in the cefoxitin group (acute salpingitis, 13; endomyometritis, 10; tuboovarian abscess, 2). An average of six bacteria were isolated from each patient. Aerobic bacteria only were recovered from 12.5%, anaerobic bacteria only in 6.5%, and both aerobic and anaerobic bacteria were present in 82.5% of patients. Overall, 21 of 23 (91%) of the piperacillin treatment group and 23 of 25 (92%) of the cefoxitin group responded to therapy with antimicrobial agents alone. The major cause of failure was the presence of an abscess. Piperacillin was shown to be an effective single agent for the management of pelvic infections caused by mixed aerobic and anaerobic bacteria. In addition, piperacillin proved to be safe and well tolerated.
Authors:
R L Sweet; M O Robbie; M Ohm-Smith; W K Hadley
Related Documents :
338025 - A double-blind trial of single-dose chemoprophylaxis with co-trimoxazole during total a...
696155 - The effect on total antimicrobial consumption and hospitalization time after prophylact...
1952835 - Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary p...
2105115 - Single dose cefotaxime plus metronidazole versus three dose cefuroxime plus metronidazo...
15519485 - Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial...
21713395 - Randomized clinical trial of postoperative strontium-90 radiation therapy for pterygia ...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  145     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1983 Feb 
Date Detail:
Created Date:  1983-03-11     Completed Date:  1983-03-11     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  342-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Bacterial Infections / drug therapy*
Cefoxitin / therapeutic use*
Clinical Trials as Topic
Female
Genital Diseases, Female / drug therapy*
Humans
Middle Aged
Penicillins / therapeutic use*
Piperacillin
Pregnancy
Chemical
Reg. No./Substance:
0/Penicillins; 35607-66-0/Cefoxitin; 61477-96-1/Piperacillin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nephrotic syndrome and immune complex glomerulonephritis associated with chlorpropamide therapy.
Next Document:  Identification of T lymphocytes in ocular adnexal neoplasms by hybridoma monoclonal antibodies.